Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis

被引:232
作者
Caulin, C
Ware, CF
Magin, TM
Oshima, RG
机构
[1] Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA
[2] La Jolla Allergy & Immunol, San Diego, CA 92121 USA
[3] Univ Bonn, Inst Genet, Abt Mol Genet, D-5300 Bonn, Germany
关键词
cytoskeleton; intermediate filament; inflammatory bowel disease; tumor necrosis factor receptor 2;
D O I
10.1083/jcb.149.1.17
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor necrosis factor (TNF) is a cytokine produced by macrophages and T lymphocytes that acts through two distinct receptors, TNFR1 (60 kD, CD120a) and TNFR2 (80 kD, CD120b), to affect cellular proliferation, differentiation, survival, and cell death. In addition to its proinflammatory actions in mucosal tissue, TNF is important for liver regeneration. Keratin 8 (K8) and keratin 18 (K18) form intermediate filaments characteristic of liver and other single cell layered, internal epithelia and their derivative cancers. K8-deficient (K8(-)) mice, which escape embryonic lethality, develop inflammatory colorectal hyperplasia, mild liver abnormalities, and tolerate hepatectomy poorly. We show that normal and malignant epithelial cells deficient in K8 and K18 are similar to 100 times more sensitive to TNF-induced death. KS and K18 both bind the cytoplasmic domain of TNFR2 and moderate TNF-induced, Jun NH2-terminal kinase (JNK) intracellular signaling and NF kappa B activation. Furthermore, K8(-) and K18(-) mice are much more sensitive to TNF dependent, apoptotic liver damage induced by the injection of concanavalin A. This moderation of the effects of TNF may be the fundamental function of K8 and K18 common to liver regeneration, inflammatory bowel disease, hepatotoxin sensitivity, and the diagnostic, persistent expression of these keratins in many carcinomas.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 35 条
[11]   INTERMEDIATE FILAMENTS - STRUCTURE, DYNAMICS, FUNCTION, AND DISEASE [J].
FUCHS, E ;
WEBER, K .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :345-382
[12]   Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappa B-dependent gene expression, and inhibiting ets activation blocks neu-mediated cellular transformation [J].
Galang, CK ;
GarciaRamirez, JJ ;
Solski, PA ;
Westwick, JK ;
Der, CJ ;
Neznanov, NN ;
Oshima, RG ;
Hauser, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) :7992-7998
[13]   RAPID COLORMETRIC ASSAY FOR CELL VIABILITY - APPLICATION TO THE QUANTITATION OF CYTO-TOXIC AND GROWTH INHIBITORY LYMPHOKINES [J].
GREEN, LM ;
READE, JL ;
WARE, CF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 70 (02) :257-268
[14]   Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30:: a role for TNF-R1 activation by endogenous membrane-anchored TNF [J].
Grell, M ;
Zimmermann, G ;
Gottfried, E ;
Chen, CM ;
Grünwald, U ;
Huang, DCS ;
Lee, YHW ;
Dürkop, H ;
Engelmann, H ;
Scheurich, P ;
Wajant, H ;
Strasser, A .
EMBO JOURNAL, 1999, 18 (11) :3034-3043
[15]   Susceptibility to Hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant [J].
Ku, NO ;
Michie, SA ;
Soetikno, RM ;
Resurreccion, EZ ;
Broome, RL ;
Oshima, RG ;
Omary, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1034-1046
[16]   CHRONIC HEPATITIS, HEPATOCYTE FRAGILITY, AND INCREASED SOLUBLE PHOSPHOGLYCOKERATINS IN TRANSGENIC MICE EXPRESSING A KERATIN-18 CONSERVED ARGININE MUTANT [J].
KU, NO ;
MICHIE, S ;
OSHIMA, RG ;
OMARY, MB .
JOURNAL OF CELL BIOLOGY, 1995, 131 (05) :1303-1314
[17]   POSTTRANSLATIONAL REGULATION OF KERATINS - DEGRADATION OF MOUSE AND HUMAN KERATIN-18 AND KERATIN-8 [J].
KULESH, DA ;
CECENA, G ;
DARMON, YM ;
VASSEUR, M ;
OSHIMA, RG .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (04) :1553-1565
[18]   In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis [J].
Kusters, S ;
Tiegs, G ;
Alexopoulou, L ;
Pasparakis, M ;
Douni, E ;
Kunstle, G ;
Bluethmann, H ;
Wendel, A ;
Pfizenmaier, K ;
Kollias, G ;
Grell, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) :2870-2875
[19]  
LEIST M, 1995, AM J PATHOL, V146, P1220
[20]  
Loranger A, 1997, AM J PATHOL, V151, P1673